… levels than those without virological response at baseline. … and baseline characteristics of
entecavir-treated patients with … ), had been positive for hepatitis B surface antigen (HBsAg) for …

… Patients were monitored till 48 weeks with baseline and … Serum hepatitis B core-related
antigen levels failed to predict … , facilitating the analysis of solely entecavir-treated patients. …

… predict HBsAg loss within 1–3 years. Data also suggest that … few patients achieve sustained
hepatitis B surface antigen (… value for a sustained virological response 24 weeks after the …

… important indicator in clinical practice, at least baseline HBV DNA was a good predictor to
determine virological response and resistance. The prediction score system in this study only …

… The baseline characteristics of the patients are included in … However, virological response
pattern observed in NUC- or … in predicting HBeAg seroconversion in entecavir-treated HBeAg-…

… virologic response rates and HBeAg and HBsAg seroclearance rates in the entecavir-treated
patients … lower HBV DNA level) at baseline has been shown to predict better virologic …

… the serum level of the surface antigen of the hepatitis B virus (HBsAg), … higher at baseline in
our HBeAg-positive patients with an … Second, the quantification of HBV RNA in serum can be …

… Demographics and baseline characteristics of patients were … of patients and a failure to
achieve virological response at … Fourth, there was no information on the quantitative HBsAg level …

… , we selected patients with CHB (Hepatitis B Surface Antigen (… After baseline enrollment,
the following criteria were used to … for HBV RNA levels in predicting response to ETV therapy. …

… 72 as our endpoint for response prediction. Also, we studied … virus RNA; qHBsAg, quantitative
hepatitis B surface antigen. … lower at baseline compared to the HBeAg-positive patients in …